A retrospective study of low-dose apatinib combined with S-1 in patients with advanced non-small cell lung cancer | Zendy

Tong Zhou | Zendy; Changling Wu | Zendy; Changsong Zhang | Zendy; Peng Li | Zendy; HuaJie Dong | Zendy; Xiaoyue Zhou | Zendy; Hongjun Lu | Zendy; Chuang Qi | Zendy; Ling Yang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A retrospective study of low-dose apatinib combined with S-1 in patients with advanced non-small cell lung cancer

Author(s) -

Tong Zhou,

Changling Wu,

Changsong Zhang,

Peng Li,

HuaJie Dong,

Xiaoyue Zhou,

Hongjun Lu,

Chuang Qi,

Ling Yang

Publication year - 2019

Publication title -

journal of thoracic disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.682

H-Index - 60

eISSN - 2077-6624

pISSN - 2072-1439

DOI - 10.21037/jtd.2019.05.33

Subject(s) - apatinib , medicine , clinical endpoint , lung cancer , retrospective cohort study , adverse effect , cancer , clinical trial , surgery , oncology , gastroenterology

The current regimens for advanced non-small cell lung cancer (NSCLC) patients are deficient due to failings in standard treatments. This retrospective study aimed to assess the efficacy and safety of low-dose apatinib in combination with S-1 therapy in a NSCLC setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research